Kidney Week 2025 is the annual meeting of the American Society of Nephrology (ASN). It offers the opportunity to exchange knowledge and engage with the latest scientific and medical advances in nephrology.
Travere at ASN Kidney Week 2025
Travere Therapeutics is excited to attend ASN Kidney Week 2025 and discuss the latest advancements in nephrology with leading experts in the field.
Program
Friday, November 7
Sparsentan vs Irbesartan in Pediatric Patients With Focal Segmental Glomerulosclerosis (FSGS) in the Phase 3 DUPLEX Trial
Speakers: Michelle N Rheault, Katherine M Dell, Kenneth Lieberman, Kevin Meyers, Ana Paredes, Edward Murphy, Jula Inrig, Radko Komers, and Howard Trachtman
Session: Pediatric Nephrology: CKD, ESKD, and Glomerular Diseases, Exhibit Hall
Type: Poster – Coming Soon
Time:
Friday: 10:00 a.m. – 12:00 p.m. (CST)
Meet a Travere MSL
Our Medical Science Liaisons (MSLs) are available to answer questions and provide support on Travere products.
Schedule a meetingSparsentan (SPAR) in Participants With Focal Segmental Glomerulosclerosis (FSGS) and Collagen Type IV Alpha 3-5 Chain (COL4A3-5) Variants
Speakers: Jennifer Yee, Howard Trachtman, Michelle Rheault, Patricia W Bedard, Angela Gruber, Wu Gong, Radko Komers
Session: Glomerular Clinical Trials: From Data to Impact, Exhibit Hall
Type: Poster – Coming Soon
Time:
Friday: 10:00 a.m. – 12:00 p.m. (CST)
Evaluation of Cardiovascular Risk Factors, Structure, and Function in an Interim Analysis of the SPARTAN Study: Sparsentan as First-Line Treatment of Incident Patients With IgA Nephropathy
Speakers: Chee Kay Cheung, Neeraj Dhaun, Sian V. Griffin, Bruce M. Hendry, Alexandra L. Howson, Radko Komers, Alex Mercer, Stephanie Moody, Kelly Parke, Matthew Sayer, Smeeta Sinha, Lisa Willcocks, Jonathan Barratt, Matthew Graham-Brown
Session: Glomerular Clinical Trials: From Data to Impact, Exhibit Hall
Type: Poster – Coming Soon
Time:
Friday: 10:00 a.m. – 12:00 p.m. (CST)
The Effect of Sparsentan (SPAR) on Proteinuria and Urinary Inflammatory and Profibrotic Biomarkers by Baseline Proteinuria Strata in SPARTAN Study Participants With IgA Nephropathy (IgAN)
Speakers: Chee Kay Cheung, William A Barratt, Neeraj Dhaun, Siân Griffin, Bruce Hendry, Amal A A Jama, Ishika Khan, Radko Komers, Alex Mercer, Stephanie Moody, Nadia Nawaz, Matthew Sayer, Smeeta Sinha, Lisa Willcocks, Jonathan Barratt
Session: Glomerular Clinical Trials: From Data to Impact, Exhibit Hall
Type: Poster – Coming Soon
Time:
Friday: 10:00 a.m. – 12:00 p.m. (CST)
PROTECT Post Hoc Analysis: Efficacy of Sparsentan (SPAR) vs Irbesartan (IRB) in Patients (Pts) With IgA Nephropathy ≤12 mo vs >12 mo From Kidney Biopsy
Speakers: Shikha Wadhwani, Jonathan Barratt, Radko Komers, Stephanie Moody, Vladimir Tesar
Session: Glomerular Clinical Trials: From Data to Impact, Exhibit Hall
Type: Poster – Coming Soon
Time:
Friday: 10:00 a.m. – 12:00 p.m. (CST)
Estimating the Benefits of Proteinuria Reduction on Kidney Failure Risk in the DUPLEX Study Using Aligned FSGS Cohort From the UK RaDaR Registry
Speakers: Alex Mercer, Daniel P. Gale, Bruce M. Hendry, Radko Komers, Edward Murphy, David Pitcher, Howard Trachtman, Moin A. Saleem
Session: Glomerular Disease Outcomes: Measuring What Matters, Room 310A
Type: Oral Presentation – Coming Soon
Time:
Friday: 5:00 – 5:10 p.m. (CST)
Impact of Histology on Efficacy of Sparsentan Therapy in IgA Nephropathy: Central Biopsy Review of Patients in the PROTECT Trial
Speakers: Ian Roberts, Bruce Hendry, Alex Mercer, Stephanie Moody, Edward Murphy, Radko Komers
Session: Glomerular Disease Outcomes: Measuring What Matters, Room 310A
Type: Oral Presentation – Coming Soon
Time:
Friday: 5:10 – 5:20 p.m. (CST)
Saturday, November 8
Outcomes of Renal Transplantation in Primary Glomerulonephritis (GN) Mapped to Post-Transplant Proteinuria in the UK RaDaR Registry
Speakers: Daniel P. Gale, Alex Mercer, Jonathan Barratt, Durga Anil K Kanigicherla, Rachel B. Jones, Thomas Oates, Alan D. Salama, Moin A. Saleem, Sapna Shah, Roslyn J. Simms, A. Neil Turner, Edwin K. Wong, Bruce M. Hendry, David Pitcher
Session: Transplantation: Clinical Controversies in Donation, Access, Monitoring, and Treatment, Room 370A
Type: Oral Presentation – Coming Soon
Time:
Saturday: 5:40 – 5:50 p.m. (CST)
Case Series: Proteinuria Reductions With Sparsentan (SPAR) Combined With Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2is) in Adults With IgA Nephropathy (IgAN) at a Single Site
Speakers: Ankit Mehta, Gustavo Borda Sanchez, Alexandra R Willcockson, Agness Pelts Block
Session: Glomerular Case Reports: ANCA, IgA, IgG, and More, Exhibit Hall
Type: Poster – Coming Soon
Time:
Saturday: 10:00 a.m. – 12:00 p.m. (CST)
Real-World Data on Low Proteinuria With Sparsentan (SPAR) in Patients (Pts) With IgA Nephropathy (IgAN): A Case Series
Speakers: Raymond Hsu, Grace Choi, Christie Izutsu, Mohammad Kamgar, Niloofar Nobakht, Basmina Parmakhtiar, Agness Pelts Block, Nasim Wiegley, Lisa Willcocks, Matthias Kretzler, Jonathan Barratt
Session: Glomerular Case Reports: ANCA, IgA, IgG, and More, Exhibit Hall
Type: Poster – Coming Soon
Time:
Saturday: 10:00 a.m. – 12:00 p.m. (CST)
MA-DS-25-0077 | September 2025